Hematopathology at Mayo Clinic
Pathology
Dr. Curtis A. Hanson, MD
|
|
Give Review
Curtis Hanson works in the field of Pathology. He attended University of Iowa Carver College of Medicine. University of Iowa Carver College of Medicine has a rank of 29 in research and a 16 in primary care Doctor Curtis A. Hanson, MD has written publications. He has 38 publications published with PubMed. The lastest publication is: 'Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis.' Curtis Hanson accepts all Medicare patients.
Publications
- A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic Leukemia in old...
- Splenomegaly and Thrombosis risk in Essential Thrombocythemia: the Mayo Clinic Experience.
- Calreticulin (CALR) variant stratified driver mutational status and prognosis in essential thrombocythemia.
- Use of the Optum Labs Data Warehouse To Assess Test Ordering Patterns for Diagnosis of Helicobacter pylori Infection in the United States.
- Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast Cells.
- Mutations and Thrombosis in essential thrombocythemia: prognostic interaction with age and Thrombosis history.
- A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.
- Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis.
- Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic Leukemia: A Mayo Clinic-French Consortium Study.
- Calreticulin mutations and long-term survival in essential thrombocythemia.
- Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients.
- Incidence of chronic lymphocytic Leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
- Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact.
- The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.
- Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review.
- CALR mutations are infrequent in WHO-defined refractory Anemia with ring sideroblasts.
- Hematological Diseases: Prototypical conditions requiring the diagnostic and prognostic use of molecular data.
- U2AF1 mutations in primary myelofibrosis are strongly associated with Anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype.
- Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary Myelodysplastic syndromes.
- Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic Leukemia (CLL).
- Mayo prognostic model for WHO-defined chronic myelomonocytic Leukemia: ASXL1 and spliceosome component mutations and outcomes.
- Diffuse large B-cell lymphoma (Richter syndrome) in patients with Chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.
- Clonal mast cell Disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis.
- CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic Leukemia.
- SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic Leukemia (CMML): independent prognostic impact in CMML.
- Long-term repair of T-cell synapse activity in a phase 2 trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated Chronic lymphocytic...
- Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic Leukemia with alemtuzumab an...
- Increased circulating IL-2R? (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype study.
- Infectious complications among individuals with clinical monoclonal B-cell Lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.
- A Case of Nonleukemic Myeloid Sarcoma With FIP1L1-PDGFRA Rearrangement: An Unusual Presentation of a Rare Disease.
- Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic Leukemia: Prevalence, clinical correlates, and prognostic relevance.
- TET2 mutations and their clinical correlates in Polycythemia vera, essential thrombocythemia and myelofibrosis.
- B-cell count and survival: differentiating chronic lymphocytic Leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
- Validation of a new prognostic index for patients with chronic lymphocytic Leukemia.
- Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic Leukemia.
- Chronic Eosinophilic Leukemia-Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma.
- Imetelstat therapy in refractory Anemia with ring sideroblasts with or without thrombocytosis.
Schools
Roy J Lucille a Carver College Of Medicine At University Of Iowa
University Of Minnesota
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Education
-
University of Minnesota at Fairview -
University of Iowa Carver College of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1558340927 |
| Last Name Of The Provider | HANSON |
| First Name Of The Provider | CURTIS |
| View All |
Similar Doctors
|
|
Dr. James D. Hoyer, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Carrie Y. Inwards, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. William L. Nichols, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. Kerr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Dingli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dong Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preet P. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aleh Bobr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy B. Gibson, DO |
|
|
Dr. Min Shi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kanaka-Durga S. Vege, MD |
|
|
Dr. Rachael A. Vaubel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Matthew T. Howard
This Doctor is OpenDoctor Recommended.
|